FDA head: Taking hydroxychloroquine ‘ultimately a decision between a patient and their doctor’

The decision to take hydroxychloroquine, an anti-malaria drug President Trump has championed as a potential coronavirus treatment, should be made by a patient and their doctor, Food and Drug Administration (FDA) Commissioner Stephen Hahn said Tuesday. “The decision to take any drug is ultimately a decision between a patient and their doctor. Hydroxychloroquine and chloroquine are already FDA-approved for treating malaria, lupus, and rheumatoid…